Reaktion #1878210

ord-8e1a81dcc4f34c74882563a072dc0774

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    Sonstigeprepared
  2. 2
    workup.STIRRINGAfter stirring for 5 minutes
  3. 3
    SonstigeAfter separating the organic and aqueous phases
  4. 4
    Extraktionthe aqueous phase is extracted three times with dichloromethane
  5. 5
    WaschenThe combined organic phases are washed with brine
  6. 6
    Sonstigeare dried
  7. 7
    Einengenare finally concentrated under vacuum
  8. 8
    SonstigeThe crude reaction product
  9. 9
    Sonstigeis then purified by chromatography on silica gel (ethyl acetate/heptane 25/75)

Vorschrift

0.072 ml (1.1 equivalents) of 1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone and then 0.6 ml (1.1 equivalents) of 1.06M lithium bis(trimethylsilyl)amide in tetrahydrofuran are added at ambient temperature to 195 mg (0.55 mmol) of methyl 3-methylene-5-(phenylsulfonyl)-2,3,4,5-tetrahydro-1-benzoxepin-7-carboxylate, prepared according to example 1, in solution in 5 ml of tetrahydrofuran. The reaction medium then assumes a dark yellow color. After stirring for 15 minutes, 0.073 ml (1.1 equivalents) of benzyl bromide is added. After stirring for 5 minutes, water, 1N hydrochloric acid and dichloromethane are added. After separating the organic and aqueous phases, the aqueous phase is extracted three times with dichloromethane. The combined organic phases are washed with brine, are dried and are finally concentrated under vacuum. The crude reaction product is then purified by chromatography on silica gel (ethyl acetate/heptane 25/75) to provide 211 mg (86%) of methyl 5-benzyl-3-methylene-5-(phenylsulfonyl)-2,3,4,5-tetrahydro-1-benzoxepin-7-carboxylate in the form of a white solid; M.p.=164–165° C.

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US07071340B2uspto-grants-2006_07